Examines theoretical, methodologic, and research issues as well as strengths, limitations, and possible interactions pertaining to behavioral, cognitive, and pharmacological treatments of panic disorder with agoraphobia. Compares attrition, outcome, and maintenance effects and presents composite indices of significant improvement, endstate functioning, and longitudinal adjustment. Discusses advantages and limitations of current treatments, emerging models, theoretical advances, and promising interventions. (Author/PVV)